Both CCL2 and CXCL16 are expressed in tumor tissues, such as lung carcinoma, hepatocellular carcinoma, colorectal cancer, and brain and ovarian cancers, hence it is possible that they play a role in the migration of MSC into tumors (49–51). The gene discussed is CCL2; the disease is neoplasm.